D. Fletcher

发表

Challenges in initiating antiretroviral therapy in 2010.

C. Tremblay, M. Tyndall, S. Shafran, 2010, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Challenges in initiating antiretroviral therapy in 2010

C. Tremblay, M. Tyndall, S. Shafran, 2010 .

Immunologic Effectiveness of Maraviroc- and Raltegravir-Containing Regimens (R+M+) versus Raltegravir-Based Regimens That Do Not Include Maraviroc (R+M−)

C. Kovacs, T. Antoniou, M. Loutfy, 2012, Journal of the International Association of Physicians in AIDS Care.

Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals

J. Rehm, C. Kovacs, M. Loutfy, 2016, AIDS care.

Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.

M. Sherman, L. Cohen, J. Heathcote, 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Trends and Correlates of Cigarette Smoking and Its Impacts on Health‐Related Quality of Life Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study, 2008–2014

A. Burchell, S. Rourke, J. Raboud, 2017, AIDS patient care and STDs.

Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen

C. Kovacs, M. Loutfy, B. Varriano, 2019, International journal of STD & AIDS.

Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapy.

C. Kovacs, T. Antoniou, M. Loutfy, 2007, AIDS patient care and STDs.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Impact of Baseline NNRTI Resistance in Antiretroviral-naÃ¯ve Patients with HIV in A Large Urban Clinic

C. Kovacs, M. Loutfy, B. Varriano, 2018 .

Effects of antioxidant vitamin supplementation in patients with HIV infection

C. Kovacs, C. Tam, S. Walmsley, 1997 .

Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles

C. Kovacs, M. Loutfy, W. Barrie, 2016, HIV clinical trials.

Reducing Read Time of Point of Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA.

J. Lazarus, H. Janssen, J. Feld, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate– to tenofovir alafenamide–containing ART among individuals with HIV in Canada: A retrospective study

C. Kovacs, Meenakshi Gupta, M. Loutfy, 2021, International journal of STD & AIDS.

38. Anal cancer screening in HIV primary care: uptake and outcomes

C. Kovacs, J. Raboud, L. Calzavara, 2013 .

The link between sexually transmitted disease clinics and HIV counseling and testing centers: who is not getting referred?

D. Ostrow, D. Fletcher, J. Joseph, 1992, AIDS Education and Prevention.

Virologic and Immunologic Impact and Durability of Enfuvirtide-Based Antiretroviral Therapy in HIV-Infected Treatment-Experienced Patients in a Clinical Setting

C. Kovacs, T. Antoniou, M. Loutfy, 2007, HIV clinical trials.

Immunologic Effectiveness of Maraviroc- and Raltegravir-Containing Regimens (R+M+) versus Raltegravir-Based Regimens That Do Not Include Maraviroc (R+M−)

C. Kovacs, T. Antoniou, M. Loutfy, 2012, Journal of the International Association of Physicians in AIDS Care.